Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M155Revenue (TTM) $M45.7Net Margin (%)3.3Altman Z-Score-2.3
Enterprise Value $M163EPS (TTM) $0.0Operating Margin %-77.6Piotroski F-Score3
P/E(ttm)280Beneish M-Score2.6Pre-tax Margin (%)-31.6Higher ROA y-yY
Price/Book5.910-y EBITDA Growth Rate %--Quick Ratio1.2Cash flow > EarningsN
Price/Sales3.45-y EBITDA Growth Rate %--Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)1.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)15.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M55.5ROIC % (ttm)-1,743.7Gross Margin Increase y-yN

Gurus Latest Trades with BDSI

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BDSI is held by these investors:



BDSI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sirgo Mark APresident and CEO 2017-09-21Sell201,373$2.84-1.41view
Sirgo Mark APresident, CEO & Vice Chairman 2017-03-31Sell110,895$1.947.37view
De Paolantonio Ernest RobertCFO, Secretary and Treasurer 2017-03-23Sell170$1.947.37view
Vasisht NirajSVP & Chief Technology Officer 2017-03-23Sell530$1.947.37view
ODONNELL FRANCIS E JRDirector 2017-03-23Sell750$1.947.37view
Vasisht NirajSVP & Chief Technology Officer 2017-03-01Sell42,000$1.9841.41view
De Paolantonio Ernest RobertSee Remarks 2017-03-01Sell19,750$1.9742.13view
ODONNELL FRANCIS E JRDirector 2017-02-17Sell129,860$1.9146.6view
Vasisht NirajSee Remarks 2017-01-30Sell6,905$1.9146.6view
SEARS SAMUEL P JRDirector 2016-12-01Sell12,000$1.6767.66view

Quarterly/Annual Reports about BDSI:

News about BDSI:

Articles On GuruFocus.com
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenb Sep 19 2017 
BioDelivery Sciences Announces Granting of Market Authorization Transfer by Health Canada for BELBUC Sep 12 2017 
BioDelivery Sciences Presents Data on BELBUCA® (buprenorphine) Buccal Film at the PAINWeek 2017 Con Sep 07 2017 
BioDelivery Sciences to Present at the Rodman & Renshaw 19th Annual Global Investment Conference Aug 24 2017 
BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End W Aug 23 2017 
BioDelivery Sciences to Present Three Posters on BELBUCA® and BUNAVAIL® at PAINWeek 2017 Aug 17 2017 
BioDelivery Sciences Reports Second Quarter 2017 Financial Results and Provides Corporate Update Aug 09 2017 
BioDelivery Sciences Publishes Shareholder Letter with Mid-Year Corporate Update Jul 31 2017 
/C O R R E C T I O N -- BioDelivery Sciences International, Inc./ Jul 28 2017 
BioDelivery Sciences Signs Exclusive Agreement With Purdue Pharma (Canada) For The Licensing And Dis Jul 12 2017 

More From Other Websites
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the... Sep 19 2017
BioDelivery Sciences Announces Granting of Market Authorization Transfer by Health Canada for... Sep 12 2017
BioDelivery Sciences Presents Data on BELBUCA® (buprenorphine) Buccal Film at the PAINWeek 2017... Sep 07 2017
Corporate News Blog - BioDelivery Sciences CEO Dr. Mark A. Sirgo to Retire at Year-End; Will... Aug 25 2017
BioDelivery (BDSI) CEO Mark Sirgo to Retire by 2017 End Aug 24 2017
BioDelivery Sciences to Present at the Rodman & Renshaw 19th Annual Global Investment Conference Aug 24 2017
BDSI CEO to retire Aug 23 2017
BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End... Aug 23 2017
BioDelivery Sciences to Present Three Posters on BELBUCA® and BUNAVAIL® at PAINWeek 2017 Aug 17 2017
Edited Transcript of BDSI earnings conference call or presentation 9-Aug-17 8:30pm GMT Aug 16 2017
Today's Research Reports on Stocks to Watch: Portola Pharmaceuticals and BioDelivery Sciences... Aug 11 2017
BioDelivery (BDSI) Q2 Loss Wider than Expected, Stock Falls Aug 10 2017
BioDelivery reports 2Q loss Aug 09 2017
BioDelivery Sciences Reports Second Quarter 2017 Financial Results and Provides Corporate Update Aug 09 2017
Investor Network: BioDelivery Sciences International, Inc. to Host Earnings Call Aug 09 2017
What's in Store for BioDelivery (BDSI) This Earnings Season? Aug 07 2017
ETFs with exposure to BioDelivery Sciences International, Inc. : August 7, 2017 Aug 07 2017
BioDelivery Sciences Publishes Shareholder Letter with Mid-Year Corporate Update Jul 31 2017
/C O R R E C T I O N -- BioDelivery Sciences International, Inc./ Jul 28 2017
Corporate News Blog - BioDelivery Sciences Collaborates with Canada's Purdue Pharma for Exclusive... Jul 14 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}